A randomised phase III study in advanced oesophageal carcinoma to compare dysphagia in patients treated with radiotherapy versus chemo-radiotherapy.

People with cancer of the oesophagus (gullet) often have trouble swallowing. Radiotherapy can help improve this problem. Using chemotherapy together with radiotherapy may work better but has more side effects. This trial will determine if it is better to use radiotherapy by itself or together with chemotherapy.

Primary Sponsor

Trans Tasman Radiation Oncology Group (TROG)

Collaborating Groups

NCI CTG (ES 2)

Final Accrual

220

Trial Chairperson

Dr Michael Penniment, Royal Adelaide Hospital, SA

Trial Contact

sonya.stephens@health.sa.gov.au

Clinical Trial Registration

Related Post

Prof Paul Keall, Image X Director and VITaL trial chief investigator
15 May, 2025

Grant for trial of new imaging technique to reduce radiation therapy side effects in lung cancer

LATEST NEWS: 15 May 2025 A novel imaging modality

HeSANDA database for clinical trial data
21 April, 2025

Trial data-sharing made easier with HeSANDA initiative

Latest News: 21 April 2025 TROG Cancer Research is